Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

11 results
Display

Reactivation of Hepatitis B Virus and Its Prevention in Patients with Rheumatic Diseases Receiving Immunosuppressive Therapy

Park EJ, Choi KS, Song BC

Introduction of biologic agents to treat patients with rheumatic diseases and cancer has improved clinical outcomes. However, this advance increases the risk of hepatitis B virus (HBV) reactivation in hepatitis...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Role of Bile Acid Receptors in Chronic Inflammatory Diseases

Park R, Ji JD

With recent developments, biologic therapies has shown superior efficacy for rheumatic diseases compared with preexisting pharmacologic therapies, which are associated with high costs, non-response in certain patient groups, and severe...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Recurrent Aseptic Meningitis in Kikuchi-Fujimoto Disease: A Not So Benign Disease?

Park JE, Park JH, Lee KH

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Association between Treatment with Biologic Agents and the Incidence of Herpes Zoster in Rheumatoid Arthritis

Lim DH, Kim YG

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cardiovascular and Gastrointestinal Effects of Etoricoxib in the Treatment of Osteoarthritis: A Systematic Review and Network Meta-analysis

Kim D, Cho SK, Nam SW, Kwon HH, Jung SY, Jeon CH, Im SG, Kim D, Jang EJ, Sung YK

OBJECTIVE: To estimate the cardiovascular (CV) and gastrointestinal (GI) risks of etoricoxib in the treatment of osteoarthritis (OA) compared to a placebo and other non-steroidal anti-inflammatory drugs (NSAIDs). METHODS: A systematic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Focal Eosinophilic Myositis Associated with Behçet's Disease

Eun JS, Kang JW, Kang JY, Kim NR, Lee SJ, Kang YM, Han MH, Nam EJ

Behçet's disease (BD) is a systemic vasculitis commonly accompanied by recurrent mucosal ulceration and other systemic manifestations, but rarely by myositis. Focal eosinophilic myositis is the most limited idiopathic eosinophilic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of the Disease Activity Score-28 Based on the Erythrocyte Sedimentation Rate and C-reactive Protein in Rheumatoid Arthritis

Choi IA

OBJECTIVE: Assessing the disease activity is a key part of clinical decision-making in rheumatology. In particular, a high disease activity, which is represented by a disease activity score-28 (DAS28) score...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pancreatic Neuroendocrine Tumor Presenting with Arthritis and Panniculitis

Kim HR, Ahn JS, Noh JH, Jeon HJ, Oh JS, Choi SW, Lim DH

Pancreatic neoplasm is complicated and can be preceded by extra-pancreatic manifestations, such as cutaneous and musculoskeletal symptoms. Awareness of these associations is important for timely diagnosis and appropriate treatment. We...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Acquired Hemophilia A Combined with Systemic Lupus Erythematosus: A Case Report and Literature Review

You J, Kim H, Park JS, Chang MH, Lee CH

Acquired hemophilia A (AHA) is a rare hemorrhagic disorder caused by autoantibodies against factor VIII (FVIII). An 80-year-old woman presented multiple bruises on her upper and lower extremities, along with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Association of Neutrophil to Lymphocyte Ratio, Platelet to Lymphocyte Ratio, and Mean Platelet Volume with Systemic Lupus Erythematosus Disease Activity: A Meta-analysis

Lee YH, Song GG

OBJECTIVE: A series of common blood tests neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), and mean platelet volume (MPV) could provide a measure of systemic lupus erythematosus...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Interleukin-17 Enhances Germinal Center Formation and Immunoglobulin G1 Production in Mice

Lee J, Lee SY, Kang CM, Jhun JY, Kim JH, Cho ML, Park SH, Kim HY, Kwok SK

OBJECTIVE: Interleukin (IL)-17 is a pro-inflammatory cytokine that has pleiotropic effects on multiple target cells and thereby contributes to the development of immune-mediated inflammatory disorders. However, the role of IL-17...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr